
BrafBombers
@brafbombers
BrafBombers is a biomarker group in Lung cancer. We are always stronger together
ID: 1356718088604037121
http://brafbombers.org 02-02-2021 21:36:59
13 Tweet
202 Followers
54 Following

THIAN SEONG YEE
@fx_tsy

Jim Straw
@orch_ca

Taher Abu Hejleh
@taherabuhejleh
Hematologist and Medical Oncologist at Abdali Hospital. @AbdaliHospital @UIowaCancer @IASLC
Aleida Vivallo
@leidosky
Pathologist.
Doña Raggedy ANN
@anicillopaz
Cuenta personal, opiniones chapinas, sin censura 🤘
Kristien Miller
@kristienjm

Sole 👩
@remariaelena
Siempre tengo que estar a punto de viajar
JANICE
@jkuts

Lauren Raguzin
@laurenraguzin
Change Management, Employee and Executive Communications, My passion...Communicating, Collaborating and Executing and Giving Back! All views are my own!
Jack Callahan
@callahanjack
Retired engineer and energy efficiency technology researcher. Interested in science, technology, society. Currently following treatments for NSCLC, EGFR+.
Alan Reyes-M.D
@dralanreyesonco
Medical Oncologist/ Int Medicine 🩺🧬🦀. Board Certified @TecdeMonterrey & @cuccuanl
Rita Leporati
@ritalepp
Medical Oncologist | Research Fellow @UNIMORE_univ | trained @IstTumori | #lungcancer
Peter
@flying36000feet
Vocation: Precision medicine. Frequent traveler. Fan of NHL, NFL, air and space travel, hotels. NY native.
VISHAL FALKE
@falke_vishal
Oncology Strategist | Unveiling Growth Pathways for Leaders & Innovators in Pharma and Biotech
Drew Moghanaki
@drewmoghanaki
MD, MPH - Lung Cancer Specialist and Professor, David Geffen School of Medicine at UCLA | Co-Director, Lung Precision Oncology Program, VA Greater Los Angeles
Amador
@amartinezl_9
✌👉😉😆
DAVA Oncology
@davaonc
DAVA Oncology is a strategic consulting company committed to delivering high quality oncology education and expanding access novel cancer therapies.
Alexandre Reuben, Ph.D.
@areubenphd
Assistant Professor / Immunologist @MDAndersonNews @GSBSImmunology Department of Thoracic / Head & Neck Medical Oncology reubenlab.com
Anja
@anjaeisenhardt

METCrusaders
@metcrusaders
Multi-stakeholder biomarker group for cancer pts diagnosed w/ MET exon 14 skipping; MET amplification; or MET overexpression. To join: [email protected]
LUNG CONNECT
@lung_connect
COR2ED bringing you Independent Medical Education developed by LUNG CONNECT, international experts in thoracic oncology. cor2ed.com/community-guid…
The Lung Cancer Genetics Study
@lcgeneticsstudy
Your DNA might be the key to understanding #LungCancer. Learn more and sign up today! #LCSM
Cecilia Pompili MD PhD FACS
@pompili_cecilia
General Thoracic Surgeon, Associate Professor focusing on patient reported outcomes (PROMs) in lung cancer care @HullYorkMed @ests_womenThor
DiRico
@dirico513
🫁 & Critical Care Fellow, PGY-VI. St. Luke’s University Health Network. Future Interventional Pulmonologist via University of Florida 🐊
JLongConsulting
@jl_npconsulting

Caitlin Nichols, PhD
@caitlinanichols
Science Program Manager @ 23andMe Lung Cancer Genetics Study | @Harvard Biomedical Sciences PhD | #lungcancer #scicomm #raredisease | Views my own
ROS1agnostic
@ros1agnostic
Because everyone deserves the best diagnosis and the best treatment for their disease, ROS1 agnostic is a reality. #ROS1 advocate. ALK/NTRK/JAK2/STAT/FAK/CDH1..
Philippe Lebel
@plebel24

Pasquale Pisapia
@pasqualepisapia
MD. PhD student. Assistant Professor of Anatomic Pathology. Molecular Pathology. Next generation technologies. Tissue and liquid biopsies.
Kartik Sehgal
@kartiksehgal_md
Medical Oncologist & Director, Thyroid Cancer Center @DanaFarber I Thyroid, Head & Neck + Immuno-Oncology I @AIIMS_nd @YaleIMed @BIDMChealth alumnusI
Omar Mokhtar
@omarmokhtar89
Clinical oncology specialist , Sagittarius doctor and Ahly lover
Dr. Karan Sood
@quantumonc
Stoic | Molecular Oncology | Medical Oncology | Manchester United | Metallica | CR7 | Schumacher | Federer | Bryant | Views are my own
Nick Rohs, MD
@nickrohsmd
Thoracic Medical Oncology @MountSinaiNY - Clinician, researcher, advocate, & lifelong learner. All tweets/RT are my own thoughts & opinions. #LCSM #LungCancer
Che Sturridge
@chesturridge
BRAF CANCER FIGHTER
Young Lung Cancer Initiative
@younglungcancer
A division of a 501(c)(3) organization aimed at creating visibility, empowerment, and hope for young adults diagnosed with lung cancer before the age of 50.
Titoa
@titoa666188
The factory specializes in international luxury goods high imitation business chicfaux.com
張景程
@zhngjng93925680

Alessandro Di Federico
@difedericomd
Medical Oncologist & PhD student @Unibo, IRCCS Sant’Orsola-Malpighi. Research Fellow @DanaFarber | @Harvardmed, Boston.
Lynn Abbott-McCloud
@abbottmccloud

Fawzi Abu Rous, MD
@fawziaburous
Thoracic Medical Oncologist @HenryFordHealth | @HFHemOncFellows @MSU_Medicine @UJ_MED Alum | @ASCOTECAG @LungCancerRx | Girl Dad | 🇵🇸🇯🇴🇺🇸 | Opinions = Own
Amy Bickleman
@amybickleman
Peace in my heart and quiet in my mind
Ros Bilton
@ros_bilton

Anita McGrath
@livingalk
Lung Cancer Advocate and 9+ year survivor.
Kathryn Gallaway, MD
@ke_gallaway
34 y/o G2P2 presents w/ insatiable thirst for knowledge of unknown etiology | Philosophy @RiceUniversity | MD @UTSWNews | Associate Medical Director @DAVAOnc
Marie-Julie Nokin
@mjnokin
Postdoctoral fellow in cancer biology | Resistance to targeted therapies in lung cancer
Yvonne Diaz
@yvonne_diaz_
Comms professional. Mum to twin sons & a dog. Living w stage 4 ALK+ #lungcancer. Co-founder @OncogeneCancer. Board Member @ALKPositiveInc #ResearchMatters #LCSM
Dr. Schreck
@karisa_schreck
Translational neuro-oncologist @hopkinskimmel focused on the exploitation of targetable genomic driver mutations in gliomas, particularly BRAF.
Alyson Holt
@alysonh70982913
At-home parent, Sg 4 NSCLC BRAFv600e dx 2019, mom of 4, @Stanford alum, Pittsburgh is home
Oncogene Cancer Research
@oncogenecancer
🔬 Research. Empowerment. Advocacy. Patients & families improving #LCSM outcomes via education, support & cutting-edge research
ALK+ International
@alkpositiveint
Charity focused on funding & advocating for #research to improve the life expectancy of ALK+ #CancerPatients. #TogetherWeCan further ALK+ cancer research